ACAD Gamma Exposure (GEX)

Net gamma exposure for Acadia Pharmaceuticals Inc (ACAD) options was positive at the Nov 4, 2026 close, about $790.17K per 1% move in the stock. It has been positive on 15 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.

Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.

Upgrade now

Gamma Exposure by Strike

Showing results for ACAD, 2026-11-20(m), calls & puts

       

Gamma Exposure Stats

Showing results for ACAD, 2026-11-20(m), calls & puts



Net Gamma Exposure by Expiration

Showing results for ACAD, 2026-11-20(m), calls & puts. View all expiries

       
Expiration Net GEX Call GEX Put GEX Call Wall Put Wall Gamma Flip

ACAD Gamma Exposure FAQ

What is gamma exposure (GEX)?

Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.

Is ACAD gamma exposure positive or negative?

Acadia Pharmaceuticals net gamma exposure was positive on Nov 4, 2026, at $790.17K. It has been positive on 15 of the last 20 trading days.

How has ACAD gamma exposure changed recently?

Acadia Pharmaceuticals net gamma exposure went from $119.28K on Oct 7, 2026 to $790.17K on Nov 4, 2026. That is its highest reading in 8 weeks. See the ACAD gamma exposure history for a longer view.

What is Acadia Pharmaceuticals Inc?

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise into making a difference for underserved neurological and rare disease communities around the world.

Give feedback on this chart